Ann M. Hanly

Insider Reports History

Entity
Individual
Location
C/O Vir Biotechnology, Inc., 499 Illinois Street, Suite 500, San Francisco, CA
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ann M. Hanly:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vir Biotechnology, Inc. EVP & Chief Technology Officer Common Stock 118K $1.11M $9.45 Feb 24, 2025 Direct
Vir Biotechnology, Inc. EVP & Chief Technology Officer Stock Option (Right to Buy) 65K $99.5K $1.53 Feb 22, 2024 Direct

Insider Reports Filed by Ann M. Hanly

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VIR Vir Biotechnology, Inc. Feb 24, 2025 1 -$134K 4 Feb 25, 2025 EVP & Chief Technology Officer
VIR Vir Biotechnology, Inc. Apr 1, 2024 1 -$27.3K 4 Apr 2, 2024 EVP & Chief Technology Officer
VIR Vir Biotechnology, Inc. Feb 22, 2024 3 -$124K 4 Feb 26, 2024 EVP & Chief Technology Officer
VIR Vir Biotechnology, Inc. Mar 30, 2023 1 -$59.8K 4 Mar 31, 2023 Chief Technology Officer
VIR Vir Biotechnology, Inc. Feb 22, 2023 3 -$59.8K 4 Feb 24, 2023 Chief Technology Officer
VIR Vir Biotechnology, Inc. Mar 30, 2022 1 -$68.9K 4 Mar 31, 2022 Chief Technology Officer
VIR Vir Biotechnology, Inc. Feb 22, 2022 2 $0 4 Feb 24, 2022 Chief Technology Officer
VIR Vir Biotechnology, Inc. Nov 29, 2021 1 $500 4 Dec 1, 2021 Chief Technology Officer